Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/28/2015 08/31/2015 09/01/2015 09/02/2015 09/03/2015 Date
3.23(c) 3.03(c) 2.93(c) 3.05(c) 3.45(c) Last
1 850 308 2 225 743 2 255 287 3 075 752 18 100 593 Volume
+4.87% -6.19% -3.30% +4.10% +13.11% Change
More quotes
Financials ($)
Sales 2015 22,5 M
EBIT 2015 -14,9 M
Net income 2015 -14,5 M
Debt 2015 -
Yield 2015 -
Sales 2016 15,3 M
EBIT 2016 -24,3 M
Net income 2016 -24,0 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 21,5x
Capi. / Sales 2016 31,6x
Capitalization 482 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
01:48pDJMARKET SNAPSHOT : U.S. Stocks Lose Steam As Oil Prices Pull Back
01:19pDJMARKET SNAPSHOT : U.S. Stocks Lose Steam; Nasdaq Turns Negative
10:23aDJMARKET SNAPSHOT : U.S. Stocks Climb After Draghi's Dovish Comments
09:14aDJMARKET SNAPSHOT : U.S. Stock Futures Extend Gains After Dovish ECB Comments
09:14aDJMARKET SNAPSHOT : U.S. Stock Futures Extend Gains After ECB Dovish Comments
08:19aDJMARKET SNAPSHOT : U.S. Stock Futures Rise Ahead Of Jobless Claims
08:08aDJMARKET SNAPSHOT : U.S. Stock Futures Rise Ahead Of Jobless Claims, ECB Meeting
07:14aDJMARKET SNAPSHOT : U.S. Stock Futures Rise Ahead Of Jobless Claims, ECB Meeting
More news
Sector news : Bio Therapeutic Drugs
04:10p MEDIVATION : Announces Participation at Upcoming Investor Conference
08:01a QUINTILES TRANSNATIONAL : CEO to Present at Morgan Stanley Global Healthcare Con..
07:37a QIAGEN NV : kit isolates high-quality RNA from exosomes in liquid biopsies
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
09:30a PREMARKET BIOTECH DIGEST : Hep C Vaccine, Big Month For Arrowhead, Gilead's Posi..
09:12a PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
09/02 Geron +20% AH after two positive imetelstat drug studies
09/02 PREMARKET BIOTECH DIGEST : Anti-CD Antigen Therapy, Geron Files S-3, 3 MAAs In E..
08/29 SA BIOTECH PANEL DISCUSSION : Geron And Incyte, Imetelstat And Jakafi


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions